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Skin testing remains an essential diagnostic tool in modern allergy practice.
A signifi cant variability has been reported regarding technical procedures, interpretation of 
results and documentation. This review has the aim of consolidating methodological 
recommendations through a critical analysis on past and recent data. This will allow a better 
understanding on skin prick test (SPT) history; technique; (contra-) indications; interpretation 
of results; diagnostic pitfalls; adverse reactions; and variability factors.
© 2008 SEICAP. Published by Elsevier España, S.L. All rights reserved.
Skin has an important physiological role in the internal bal-
ance homeostasis and constitutes a crucial barrier against 
external aggressions, with well-known immunological prop-
erties.1 It has been used by allergists for decades as an eas-
ily assessed laboratory of the immunological status of the 
individual.
The fi rst skin testing technique was developed by Charles 
H. Blackley in 1865, a Manchester homeopathic physician 
with allergic rhinitis. He abraded a quarter-inch area of his 
skin with a lancet and then applied grass pollen grains.2 The 
so-called scratch test was later adopted by Schloss for the 
diagnosis of food allergy in children.3 Epicutaneous tests can 
be divided into scratch tests and prick/puncture tests. The 
fi rst method, proposed by Blackley2, implied a linear scratch 
without drawing blood and could either be performed fi rst, 
with the extract then dropped on the abraded skin, or be 
made through a drop of extract.4 Although it was used ex-
tensively in the past, this technique became progressively 
obsolete due to patient discomfort, poor reproducibility, 
possible residual lesions and newer and innocuous proce-
dures.4 Therefore, scratch test is mentioned here for his-
torical purposes only. It was Sir Thomas Lewis who, in 1924, 
fi rst applied skin prick tests (SPT).5 Nevertheless, their gen-
eralised use in clinical practice only became a reality about 
30 years ago, as a result of technique modifi cations proposed 
by Pepys.6 For the purpose of this review and for easier com-
prehension, skin testing will be referred interchangeably as 
SPT, whatever device is used for its application.
In 1966, Ishizaka’s work on immunoglobulin E (IgE) and im-
mediate hypersensitivity reactions7 established the scientifi c 
corpus to what was done till then on a strictly empiric basis.
As written by Dr Walzer in 1974, “the fact that skin testing 
has not turned out to be a simple and completely reliable 
technique does not detract from the fact that, when it is 
intelligently and skilfully performed, it remains the most ef-
fective diagnostic procedure in reaginic allergic disorders”.8
The reliability of skin testing and proper documentation of 
test results are essential in allergy practice. A recent survey 
to all physician members and fellows of the American Col-
lege of Allergy, Asthma and Immunology practicing in the 
156 Antunes J et al
United States detected a signifi cant degree of variability re-
garding skin test devices, extract concentrations, interpre-
tation and documentation of results and quality assurance 
procedures.9
This heterogeneity observed in clinical practice justifi es 
the interest and relevance of the present review work. It is 
our aim to consolidate important technical recommenda-
tions, providing a new insight on the subject.
Skin prick tests
General considerations and indications
It is imperative that the clinician be fully aware of the clini-
cal indications, correct technique, and interpretation crite-
ria, as well as the risks and limitations of SPT. Skin testing 
should always be an adjunct to history and physical exami-
nation and not a substitute for medical evaluation.
SPT confi rm the diagnosis of immediate hypersensitivity 
reactions.4,10
On skin level, the IgE-mediated immune response is de-
pendent on both chemical and neurogenic mediators.11,12 
After intracutaneous injection, allergens cross-link pre-
formed IgE bound to the high-affi nity receptor FcERI mast 
cells and a complex signal transduction cascade is activated. 
This eventually culminates in mast-cell degranulation begin-
ning in seconds, with release of a variety of preformed in-
flammatory mediators. Among these are histamine — a 
short-lived vasoactive amine that causes an immediate in-
crease in local blood flow and vessel permeability — and 
enzymes such as mast-cell chymase, tryptase and serine es-
terases.11 A wheal and fl are reaction develops within min-
utes after superfi cial injection of antigen into the epidermis 
and lasts for up to 30 minutes. On activation, mast cells also 
synthesise and release chemokines, lipid mediators such as 
prostaglandins, leukotrienes and platelet-activating-factor, 
and additional cytokines such as interleukins 4 and 13 which 
perpetuate the Th2 response.11 These changes can some-
times be followed by a late-phase reaction (LPR), which is 
extremely rare and almost exclusive to patients sensitised 
to moulds, grass and parietaria pollens.13
In a positive reaction, histamine can be detected only at 
the centre of the wheal, not in the periphery. It is suggested 
therefore that after allergen challenge, the mediators re-
leased by the challenged mast cell induce an axon refl ex by 
direct stimulation of c-fi bres. This induces the release of 
neurogenic peptides and mast cell mediators from “the 
next” mast cell, becoming the major players in the immedi-
ate wheal and fl are reaction.12
Skin testing can be used to select eviction measures and/
or specifi c immunotherapy.14
To optimally defi ne test performance, a method should be 
reproducible and validated by comparison with gold stand-
ard methods. Direct challenge tests under supervision of a 
physician are appropriate ways to confi rm or refute the va-
lidity of SPT. It provides objective evidence for sensitivity, 
specificity, predictive values and likelihood ratios. When 
compared to gold standard procedures, i.e. organ challenges 
such as nasal bronchoprovocation challenge or oral provoca-
tion challenge, SPT have demonstrated good results.15-18 The 
simplicity, rapidity of performance, low cost and high sensi-
tivity make skin testing preferable to in vitro testing for de-
termining the presence of specifi c IgE antibodies (sIgE). It is 
important to note the higher sensitivity of SPT when com-
pared to sIgE dosing. Nevertheless, every positive result 
must be correlated with history and physical fi ndings since a 
positive skin reaction does not necessarily imply the diagno-
sis of allergy.19
Interpretation of skin tests is highly dependent on the 
constitutive allergenicity, potency and stability of the aller-
gen extract. For this reason, SPT sensitivity tends to be 
higher among aeroallergens, in particular pollens, house 
dust mite, fungi and certain epidermals.10
In clinical practice, skin testing has been extensively used 
for assessing sensitisation to inhalant allergens. SPT is useful 
to confi rm or exclude a suspected diagnosis of allergic rhi-
nitis, allergic conjunctivitis or asthma triggered by aller-
gens 10,20,21 and to demonstrate sensitisation to inhalant 
occupational allergens.22,23
Previous observations suggest that skin test positivity at 
an early age is associated with subsequent development of 
rhinitis and wheeze.24-26 The role of allergic sensitisation as a 
cause of eczema is less clear.27
Skin testing in food allergy is common practice as well, 
although less reliable for commercial extracts of fruits and 
vegetables, as explained below.28 The clinical utility of SPT 
in patients with food allergy suspicion, especially infants 
and children, has been evaluated in various studies using 
oral food challenges and sIgE.
Most previous studies on food allergy obtained a concord-
ance rate between SPT with commercial extracts and oral 
challenges from 60 % to 85 %28-32, specifi city being generally 
lower, in the range of 40 % to 80 %.28 A negative result is use-
ful to exclude type I reactions to food allergens (negative 
predictive accuracy > 95 %)32 but a positive result may or 
may not be associated with true clinical reactions. The over-
all concordance between a positive SPT and positive oral 
challenge differs between authors, but consensus exists re-
garding clear superiority of fresh food when compared to 
commercial extracts, as shown by Ortolani et al.33, Rosen et 
al.30, and Norgaard et al.34 With fresh food, sensitivity usu-
ally exceeds 90 % and can even reach 100 %.34 This is particu-
larly important when a strong suspicion of food allergy 
subsists after negative results with commercial extracts. 
Fresh food testing makes use of a different procedure, the 
prick-prick technique.
Under carefully defi ned circumstances, SPT can also be 
used as a primary approach to drug and hymenoptera ven-
om. In such cases however, intradermal tests are usually 
required for a correct diagnosis. For most chemicals asso-
ciated with occupational allergy it is not indicated, with 
the exception of agents known to be implicated in IgE 
 reactions, such as platinum salts, acid anhydrides, poly-
isocyanates, sulphonechloramide and succinylcholine ana-
logues. 35-37
Technique
The goal for the allergist is to perform skin testing with de-
vices which minimise both false positive and false negative 
results while reducing patient discomfort. SPT should be a 
non-traumatic procedure (blood-free) and several sharp in-
struments such as a hypodermic needle, solid bore needle, 
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lancet with or without bifurcated tip, and multiple-head de-
vices, may be used.38
Historically, in the method fi rst introduced by Pepys, the 
needle or blood lancet tip was inserted at an angle of 60.º to 
70.º to the skin surface, gently lifting the superfi cial epider-
mal layers to create a small break in the skin.6
In 1979 a new method — puncture test — was proposed by 
Østerballe & Weeke, using a lancet with 1 mm tip and shoul-
ders to prevent further penetration.39 Lancets should be 
pressed with equal strength at 90º to the skin surface 
through a drop of extract or control solutions.4 This tech-
nique appears to be more precise than the original SPT 
method proposed by Pepys.40,41
Multiheaded devices are designed to fi rst be dipped into 
the extract bottles, then applied to the skin in one step. 
They appear to be more painful than single devices but it is 
noteworthy that with a minimal increase in pain, as many as 
eight times more tests are applied, rendering multiheaded 
devices particularly useful in paediatric ages.38
Lancets should be sterilised, a fresh lancet for each prick, 
with normalised measures and each lancet should be used 
only once for each extract, in order to avoid unintentional 
pricks, blood borne infections and allergen contamination. 
Metal lancets with 1mm penetration limit are considered 
equally effi cient and less painful than other synthetic de-
vices with 1.4 or 1.6 mm penetration limits.39 The penetra-
tion limit is therefore a determinant factor when considering 
test effi cacy and patient comfort, rendering metal lancets 
preferable when compared to other synthetic devices.13 
Nevertheless, an objective comparison has not shown a 
clear-cut advantage for any single or multitest device and 
optimal results can be obtained by choosing a single prick/
puncture device, and properly training its use.38,40,42
Antiseptic solutions are recommended before SPT and skin 
should be totally dry before procedure.43
Recommendations have been made regarding the appro-
priate placement of allergen extracts. The recommended 
distance for skin prick testing has varied between 2 and 
5 cm44 and test sites should be marked with an appropriate 
code.4 It is possible, however, for a positive reaction to en-
hance false-positive skin reactions at an adjacent site, even 
over the range of 5 cm.43-45
SPT are usually performed on the volar surface of the 
forearm, at least 5 cm above the wrist and 3 cm below an-
tecubital fossae,4 the least and most reactive areas of the 
upper limb, respectively. The tests can also be done on the 
upper arm or the back, with special attention to avoid reac-
tivity differences between locations.43 It should be taken 
into account that not only is the back 20 % more reactive 
than the forearm but specifi c locations on the back vary in 
reactivity as well.46.47 Therefore, a minimum of 2 cm dis-
tance between each SPT should be adopted.
For an accurate interpretation of wheal and fl are reac-
tions to allergens, both positive and negative tests should 
be used. A negative control solution is required to evaluate 
unspecifi c reactions related to prick testing trauma (dermo-
graphism).4,48,49 A saline solution, phenol at 0.5 % or glycerine 
at 50 % are recommended.10
For positive control, histamine dihydrochloride 10 mg/ml 
(54.3 mmol/1), equivalent to 6.14 mg/ml of histamine base, 
or codeine phosphate at 9 % can be recommended.49 Some 
authors advocate the use of histamine at 1 mg/ml50; how-
ever, in a study by Morais de Almeida et al., the concentra-
tion of 1 mg/ml consistently presented negative results in 
more than 10 % of the patients.13 Therefore, histamine at 
1 mg/ml should be defi nitely abandoned.
The prick-prick test requires a different procedure, prick-
ing the food fi rst, and then the skin, using the same needle; 
or pricking the skin through food in a single manoeuvre.51 
Foods with a hard consistency, such as peanut, can be 
ground, diluted in buffered saline at 1/3 weight/volume 
(w/v), or 500 mg of food to 1.5 ml of saline.52
Dreborg recommends at least two parallel tests performed 
with the same material in every patient with the exception of 
infants, in order to assure precision, as single negative tests 
(5 %) will be obtained in sensitised patients even with skilled 
technicians.4 In duplicate tests, the diameter should not vary 
more than 1 mm.53-56 Several publications have provided in-
novative methods to assure skin test validity. A suggested pro-
tocol for quality assurance testing and profi ciency testing for 
SPT can be found in literature.10 In Europe, a  coeffi cient vari-
ation of less than 20 % after histamine control test has been 
suggested57, whereas a recent Childhood  Asthma Management 
Study considered a variation inferior to 30 %.58
Reading and interpretation
The size of the papule is of paramount importance in SPT. 
However, both erythema and wheal should be measured for 
proper interpretation.10
Østerballe and Weeke39 demonstrated that the wheal size 
with histamine peaks earlier (9-12 min) than with allergens 
(13-16 min). In a recent study, using laser Doppler fl ow im-
aging and scanning of drawn wheal sizes, the maximum his-
tamine wheal size was reached at 20 minutes.59 We therefore 
propose a consensus reading time for both positive control 
and allergen reactions at 20 minutes post-prick.
A valuable option concerning appropriate documentation 
of skin test results consists in outlining the wheal and fl are 
reaction with a felt-tip pen and transferring results with 
transparent tape to a blank sheet of paper.4,13
Various indices have been used for interpretation of skin 
reactions. The papule’s area is the most accurate49,59 and 
can be evaluated by planimetry, either directly with 
 image-processing programs or from a traced copy.13,60 The 
interpretation of the skin prick test is subject to inter-ob-
server variation. To overcome this issue, computerised pro-
cedures have been proposed, allowing a more precise area 
evaluation.60,61 Other methods such as laser Doppler tech-
nique62 and ultrasound63 have been tested with success.
The size of the reaction can also be assessed using:
•  minimal diameter;
•  mean wheal diameter, calculated as the sum of the larg-
est diameter and its largest orthogonal diameter divided 
by 2; or
•  skin index, defi ned as the ratio of allergen wheal diameter 
divided by the histamine wheal size.
The SPT result should be considered positive if:
•  minimal wheal diameter is greater than 3 mm or;
•  mean diameter is 3 mm or larger; and/or
•  skin index superior to 0.6.
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Of the criteria explained above, mean wheal diameter is 
the most commonly used.
The skin reaction is considered positive if the wheal’s area 
is 7 mm2 or higher, which corresponds approximately to a 
mean diameter of 3 mm.9,40,57,64,65
The degree of erythema (fl are) is considered to be a non-
specifi c reaction of the skin to the trauma of the puncture.66 
Nevertheless, some authors consider a positive reaction if 
the mean fl are diameter is over 10 mm.49
The results obtained can only be correctly assessed and 
taken into account with valid positive and negative control 
reactions. Thus, histamine’s papule mean diameter should 
be greater than 3 mm and negative control should not ex-
ceed 3 mm with erythema diameter inferior to 10 mm. De-
vices that systematically produce negative control wheals 
over 3 mm should be avoided.67 Stuckey et al. found that 
patients with more positive sensitisations and higher total 
IgE have larger histamine papules.68
Qualitative scoring (0 to 4+; 0 or +) is no longer recommend-
ed because of marked variability between observers. 69,70
Wheal size has assumed greater diagnostic signifi cance 
due to the positive correlation with clinical symptoms sever-
ity. 71-74 Investigating graduated test responses and establish-
ing probability decision points might improve diagnostic 
accuracy and predict positive reactions during organ chal-
lenge.75 In a previous study, especially regarding food aller-
gy, Sporik74 defined specific wheal diameters as ‘100 % 
diagnostic’. In his work, cut-off values were proposed for 
cow’s milk (≥ 8 mm), hen’s egg (≥ 7 mm) and peanut 
(≥ 8 mm), suggesting that children exceeding these limits 
are allergic to this specific food. These recent advances 
might obviate the need for oral challenge in the future.74-76 
These cut-off points vary for different allergens, being more 
accurate for cow’s milk and hen’s egg than for soy or wheat. 
Additionally, different populations may exhibit signifi cant 
variability. Even though there is a correlation between SPT 
result or sIgE and likelihood of a clinical reaction, sensitisa-
tion level does not always correlate with allergic 
manifestations.77-79
One study points to between 7.5 % and 19 % asymptomatic 
sensitisations among Finnish schoolchildren.80 Skin test reac-
tivity to inhalant allergens is reduced in asymptomatic sen-
sitisations when compared with symptomatic patients.81 
Asymptomatic sensitisation is generally considered a pre-
morbid state of allergic disease, and has been proven to be 
a risk factor for the development of allergic rhinitis in chil-
dren and young adults.82,83 Bodtger et al., in a 3-years fol-
low-up study, showed that adults with asymptomatic skin 
sensitisation to birch pollen have an increased risk (about 
60 %) of developing hay fever.82
Several studies have demonstrated that positive SPT in in-
fancy, especially to hen’s egg, predicts subsequent presence 
of eczema in childhood.83-86 Thus, sensitisation in asympto-
matic children can precede and predict the development of 
eczema.87
Limitations
In the past, the manufacture of skin test solutions imposed 
important technical limitations. The recent availability of 
standardised commercial extracts constitutes a major 
achievement in allergy testing. Allergen extracts are com-
plex mixtures derived from natural source materials and as 
such are prone to natural variation, requiring proper stand-
ardisation to ensure consistency and reproducibility. Some 
physicians report non-negligible variability between extracts 
from different manufacturers, easily attested in our daily 
practice.88,89 Quality of allergen extracts is dependent on 
several parameters such as raw material quality, proper test 
extractions, adequate processing and removal of low 
 molecular weight components by dialysis or fi ltration.90 Sta-
bility, potency and allergen concentration are also deter-
mining.
The most internationally recognised way to express aller-
gen extract strength is micrograms of major allergen be-
cause this appears to correlate well with overall biological 
potency of the extract.91 In-house references should be 
characterized with respect to dry weight, allergen complex-
ity, major allergen content and IgE binding capacity. Biologi-
cal activity should ideally be assessed in vivo, with skin 
testing.90-92 However, the methods used differ from manu-
facturer to manufacturer, making products from different 
companies impossible to compare.93
Non-related allergen mixtures may account for loss of bio-
logical potency as a consequence of excessive dilution or 
enzymatic deterioration of the epitopes. Time and higher 
temperatures can also accelerate the decay process. To as-
sure stability, allergens are usually preserved with 50 % glyc-
erine and stored under cold (4.ºC).94,95
Recombinant allergens offer future interesting perspec-
tives as in vivo diagnostic tools. These genetically engi-
neered molecules appear to be highly specific, safe and 
biologically active. Their sensitivity, however, appears to be 
lower when compared to natural allergen extracts.89,96
Which allergens to test is a common doubt in daily prac-
tice. A recent survey performed in the United States showed 
that most allergists do not rely on history when choosing 
which allergens to use to perform skin testing.9
When considering inhalant allergy, several criteria should 
be thought-out before choosing skin testing reagents, such 
as botanical and aerobiological surveys. Flowering season, 
types and levels of pollens and spores along the year and 
peak days of pollination should be considered. Annual pollen 
sampling data in various countries are now available 
on-line.97,98 Air composition and concurrent allergy symp-
toms during recurrent seasons constitute the best indicators 
in the selection of appropriate outdoor aeroallergens for 
skin testing.10
The infl uence of pollen load is more evident in sIgE chang-
es than on SPT reactions or clinical symptoms.99
Regarding food allergy, SPT can be performed both with 
commercial allergen extracts and fresh foods. Fresh food is 
often used as it more accurately refl ects the patient’s life. 
In a French study it was demonstrated that fresh foods were 
more reliable in food allergy diagnosis than commercial ex-
tracts.100 Commercial extracts of fruits and vegetables (e.g., 
apples, oranges, bananas, potatoes, carrots, and celery), 
are likely to lose biological properties with time, reinforcing 
the role of prick-prick method with fresh food.100 This tech-
nique is also valuable when there are differences in the al-
lergenicity of different cultivar strains (e.g., apples) or 
when no commercial extracts are available.101
Although prick-to-prick tests are widely used, it is impor-
tant to notice that they are not standardised, often give 
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false-positive results, and still bear the risk of systemic re-
actions, as discussed in later sections.
Instead of fresh food, freezing aliquots may facilitate skin 
prick testing in particular cases. Freezing cow’s milk and 
hen’s egg at -20.ºC has been tested and it does not alter the 
allergenic properties of each component.102 However, these 
results cannot be transferred automatically to other foods 
without further testing.
Furthermore, commercial extracts may produce false-neg-
ative results since storage, cooking or digestive process may 
induce immunological alterations in relevant allergens, ren-
dering a particular food more allergenic than achieved by 
commercial extracts.10
The presence of active cutaneous lesions, as commonly 
observed in patients with active atopic dermatitis, impair 
the proper SPT reading, and constitute a contra-indication 
to skin test procedures.4,48,103 Nevertheless, SPT can be per-
formed in eczematous infants since no lesions exist on test-
ing area. This can be useful as infants with eczema in the 
fi rst 2 years of life with concomitant allergic sensitisation 
have a greater risk of childhood asthma and allergic rhinitis 
than infants with non-atopic eczema.104
Patients with dermographism should be excluded as it is 
diffi cult to distinguish between a true or false positive re-
sult, invalidating any conclusions.4
In such circumstances involving extensive skin disease; or 
in patients under skin test suppressive therapy (for exam-
ple, antihistamines) that cannot be discontinued; uncoop-
erative patients; or when the history suggests an unusually 
high risk of anaphylaxis from skin testing, sIgE immunoassays 
may be preferable to skin testing.
False-positive reactions can be due to skin trauma, mostly 
in patients with dermographism4, as explained above, but 
also to contaminated allergen extracts (occurring during ex-
tract preparation or simply for not changing lancets during 
SPT)105 or cross-reactivity phenomena.106 Cross-reactivity de-
pends on the type of allergens involved, in particular their 
structural and sequential similarity.106 Pan-allergens respon-
sible for cross-reactivity in vegetables are pathogen-related 
proteins (PRP) and profi llins.107 For invertebrates, tropomy-
osin is the most implicated protein. For vertebrates, several 
allergens are implicated: parvalbumin (fish), livetin and 
ovotranferrin (egg and birds) and casein (milk).108
Extensive cross-reactivity has been described among aer-
oallergen-sensitised patients.10,109 House dust mites, epider-
mals, but most of all, pollens have been widely studied. 
Therefore, testing with multiple locally prevalent pollens 
may be required to avoid signifi cant omissions. Cross-aller-
genicity among major classes of airborne fungi has not been 
well delineated so far.10
With regard to food allergy, we shall briefl y mention the 
most interesting and relevant syndromes as it can be useful 
to better understand skin test results. Patients with: 1) birch 
apple; 2) artemisia-celery-carrot-spices; 3) grass-peach; 
4) plantago-melon; 5) latex-fruits; 6) dust mites-seafood; 
7) bird-egg; 8) pig-cat; 9) shellfi sh; 10) peanut, soybean and 
other legumes; 11) tree nuts; 12) rosaceous fruits; and 
13) cereal grains can be expected to show cross-reactivity 
with SPT.
Concerning false-negative results, special attention should 
be given to patient’s age, concomitant drugs and diseases 
such as HIV infection or chronic renal insuffi ciency, which 
may inhibit skin reactivity.10 Even when all quality parame-
ters are considered, patients with evident allergic symptoms 
can still have negative SPT. It is important to consider that 
non-IgE mechanisms, impossible to be assessed by SPT, can 
be implicated in patient’s complaints. Powe et al.110 demon-
strated that infl ammation in non-allergic rhinitis may be a 
consequence of localised IgE-mediated reactions, not involv-
ing systemic Th2 responses or atopy. Therefore, local IgE pro-
duction in non-allergic patients could explain the presence 
of symptoms in SPT negative patients (localised mucosal al-
lergic disease in the absence of atopy — “entopy”).110
Adverse reactions
In the last thirty years, the occurrence of systemic reactions 
with SPT for inhalant extracts has decreased dramatically.111 
Recent surveys indicate an overall risk inferior to 0.02 % for 
anaphylactic reactions to SPT, whereas IDT are more likely 
to induce systemic reactions.111 Most of the systemic reac-
tions incited by SPT were related to fresh food (prick-prick 
tests with kiwi, fi sh, fresh pine nut and milk)112-114, latex (SPT 
with natural rubber latex and commercial extracts)115,116 and 
drugs (penicillin, amoxicillin).111 In a 12-year survey of fatal 
reactions (1990-2001), one fatality was confi rmed after SPT 
with multiple food allergens (90 food prick tests were ap-
plied at one time in a patient with moderately persistent 
asthma).117
A retrospective review of medical records concerning SPT 
with foods corroborates the low rate of generalised reac-
tions, as previously stated, and points out that all reactions 
in infants (n = 6) occurred under 6 months of age and only 
with fresh food specimens.118
Special attention should be given to young children and 
pregnant women. Skin test duplication should be avoided in 
children with suspected food allergy (fresh food or commer-
cial extracts), especially when suffering from extensive ec-
zema.111 As for pregnant women, although SPT is not 
contraindicated, it is prudent to postpone such procedures 
and/or propose sIgE assays instead.111
Variability factors
Multiple factors have been found to infl uence SPT results. 
These variability factors include technical issues, biological 
determinants and other external factors such as previous 
medication or infections (Table I).
Skin reactivity is known to vary according to age: children, 
particularly under the age of 2 years, are less reactive than 
adults.119 The prevalence of positive skin test results in-
creases until the 2nd decade, with a slow decline above the 
age of 60 years.120 In children with manifest allergy, howev-
er, skin has similar reactivity from 1 year of age until puber-
ty.4 Nevertheless, SPT tests can be used in infants as young 
as 1 month, with a high degree of reliability, usually with 
more erythema than wheal reaction.119
Test results also depend on anatomic location since skin 
reactivity differs from region to region. In decreasing order, 
the degrees of reactivity are as follows: mid and upper back 
> lower back > upper arm > elbow > forearm (ulnar > radi-
al) > wrist.47
Besides age and anatomic location, other biological and 
physiological factors may also infl uence skin test results, 
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such as histologic qualities of the skin (vascularity, number 
of histamine receptors, mast cells, and dermal thickness).29 
In one study, UV-B exposure was found to reduce skin reac-
tion by as much as 48 %.121 Concerning racial factors, 
dark-skinned patients seem to have larger wheal-and-fl are 
reactions, but some authors found Caucasians to be more 
reactive than non-Caucasians.10,46
Circadian rhythm has no infl uence on skin reactivity10,122 
but some data show maximum wheal size during the night. 46 
Different studies identifi ed a relevant increase in wheal-
and-flare reaction in patients with allergic asthma and 
rhinitis after pollen season.123 On the contrary, the reduc-
tion in skin reactivity in sensitised subjects is a common 
fi nding after specifi c immunotherapy, either sublingual or 
subcutaneous. 124,125
Concurrent drugs, in particular antihistamines (AH), tricy-
clic antidepressants and topical corticosteroids may affect 
the validity of skin testing.10 Different phamacodynamic 
models have been used to evaluate the degree and duration 
of drug suppression on skin reactivity, making direct com-
parisons unreliable (Table II).
The histamine-induced wheal and fl are model helps to 
identify the objective effectiveness of AH in humans, as 
well as their differences in the onset and duration of ac-
tion. Several studies have employed this model to com-
pare AH and assess their pharmacokinetic properties. 
When compared to other 2nd generation AH, such as 
desloratadine, levocetirizine appears to be more effective 
in inhibiting wheal and fl are response.126,127 Ebastine, fex-
ofenadine, cetirizine and mizolastine rank next and have 
similar skin effects. Superior effi cacy of ebastine (20 mg) 
was found in comparison to cetirizine (10 mg) or lorata-
dine (10 mg) on the overall skin wheal response after sin-
gle and multiple doses,127 with a longer-acting effect than 
fexofenadine as well.128
The general principle concerning fi rst- and second-gener-
ation AH is to stop medication 2 to 3 days before SPT, with 
the exception of cetirizine, hydroxyzine (5 days)129, clemas-
tine (5 days)130, loratadine (7 days)131 and perhaps others not 
yet studied. For this reason, and as it seems easier for the 
patient to remember, we suggest a one-week drug-free in-
terval before skin testing.
Many patients who require SPT cannot deal with pruritus 
without taking AH. In a recent work by Danarti et al132 topi-
cal AH can be used in such circumstances. Because of their 
short duration of action (< 180 minutes), these drugs can be 
used in patients who need antihistamines but are scheduled 
to undergo skin prick testing after a few hours, without in-
fl uencing the patient’s skin response.132
Doxepin, a tricyclic antidepressant, and anti-H2 drugs can 
also cause false-negative results for as long as 6 days133 or 
24h134, respectively.
Systemic corticosteroids do not inhibit skin reactivity 
when used for short term therapy (i.e. 30 mg prednisone a 
day for 1 week).135 When used for longer periods, confl icting 
results have been obtained, recommending a more critical 
analysis.10 Topical steroids should be discontinued 2 to 
3 weeks before testing as prolonged use (over 3 weeks) can 
suppress wheal reaction in the application sites.136
Bronchodilators, epinephrine and theophylline do not sig-
nifi cantly suppress skin reactivity.137 In the case of cysteinyl 
leukotrienes antagonists (e.g. montelukast and zafi rlukast)138 
or EMLA cream139, no signifi cant effect on wheal-and-fl are 
reaction has been described either. Concerning intranasal 
topical AH (e.g. azelastine) results are somehow contradic-
tory and discontinuance is recommended for a 48h minimum 
period.10,140
Table II. List of drugs with skin inhibitory effect
Drugs and skin reactivity
Drug Dose Wheal inibitory 
effect (days)
Anti-H1 1st generation
  Clemastine  1 mg 2×/d 5-10
  Hydroxyzine 25 mg 4×/d 5-8
  Promethazine 25 mg 4×/d 3-5
Anti-H1 2nd generation
  Fexofenadine 60 mg 2×/d 2
  Loratadine 10 mg 1×/d 7
  Cetirizine 10 mg 1×/d 3
Tricyclic antidepressants
  Desipramine 25 mg 1×/d 2
  Doxepine 25 mg 1×/d 6
Cysteinyl leucotriene 
antagonists
  Montelukast 10 mg 1×/d 0
  Zafi rlukast 20 mg 1×/d 0
Local anesthetic
  EMLA cream  5 mg 0 (but supresses 
  erythema)
Anti-H2
  Ranitidine 150 mg 1 dose < 1
Table I. False results in skin prick tests
 False negative results False positive results
Biological factors Sensitisation, sex, race, age and anatomic location Dermographism
External factors Drugs, UV radiation and other diseases Cross-reactivity
Technical factors Extract quality/concentration and incorrect 
  technique
Trauma and non-blood-free procedure, 
  extract quality (impure mixtures)
SPT diagnostic limitations Non-allergic hypersensitivity and on-IgE 
  mediated reactions
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Papule size depends as well on allergen concentration and 
number of allergens tested for which the patient is sensi-
tised. Some authors have studied these variables and calcu-
lated, as an example, that the wheal diameter increases 
1:5 times (area 2:5 times) if the allergen concentration in-
creases 10 times.53,54 In polysensitised individuals, simulta-
neous prick testing with multiple allergens can induce 
additive histamine release from cutaneous mast cells. In 
vivo and in vitro studies suggest an additive effect of multi-
ple proteins (allergens mixture) on histamine release from 
cutaneous mast cells, causing mean wheal diameters larger 
than obtained with single allergens.141
Future directions
Skin testing remains an essential diagnostic tool in modern 
allergy practice. Allergen extracts have experienced great 
progress in recent years but a long way remains ahead. Many 
allergens have yet to be characterized. The quality of ex-
tracts still needs further advances, with criterious allergen 
selection and biologic potency assessment. The capacity to 
differentiate between clinically irrelevant and relevant sen-
sitisations constitutes an important motivation to future in-
vestigations. The defi nition and use of recombinant allergens 
promises to lead to an improvement in this area, eliminating 
diagnostic errors due to cross-reactivity phenomena.
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